Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca's Calquence Steps Into Blood Cancer Ring With Mighty Imbruvica

Nov 01 2017

• By Emily Hayes

FDA Approved typed words on a vintage typewriter

Related Content

CLL Market Snapshot: Seismic Changes Rock The Treatment Landscape

Oct 20 2014

AstraZeneca In Buy Now, Pay In Full Later Deal For Majority Acerta Stake

Dec 17 2015

New AbbVie Guidance Sets High Bar For Post-Humira Pipeline

Oct 28 2017

AstraZeneca Says 'IDO' To Incyte For Imfinzi Marriage

Oct 31 2017

Fast-To-Market Play For AstraZeneca's Acalabrutinib With MCL Filing

Aug 02 2017

Venetoclax And Other New Kids On The Block Shine At ASH

Dec 14 2015

Related Companies

AstraZeneca PLC

Johnson & Johnson

Acerta Pharma BV

Teva Pharmaceutical Industries Ltd.

Roche Holding AG

AbbVie Inc.

Additional Topics

Approvals Research & Development Commercial Cancer BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window